MedPath

陕西九州制药有限责任公司

Ownership
-
Established
2003-04-29
Employees
-
Market Cap
-
Website
http://sxjz.net.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Paracetamol and Tramadol Hydrochloride Tablets

Product Name
氨酚曲马多片
Approval Number
国药准字H20080130
Approval Date
Nov 1, 2022
NMPA

Paracetamol and Dihydrocodeine Tartrate Tablets

Product Name
氨酚双氢可待因片
Approval Number
国药准字H20073626
Approval Date
Jun 1, 2022
NMPA

复方鱼腥草片

Approval Number
国药准字Z20054129
Approval Date
Aug 14, 2015
NMPA

Amantadine Hydrochloride Granules

Product Name
盐酸金刚烷胺颗粒
Approval Number
国药准字H20103537
Approval Date
Aug 31, 2010
NMPA

Puerarin Injection

Product Name
葛根素注射液
Approval Number
国药准字H20055204
Approval Date
May 26, 2005
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.